Spearhead Capital Advisors’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-24,303	Closed	-$169K	–	219
2021 Q4	$169K	Buy	24,303 +373	+2%	+$2.59K	0.02%	172
2021 Q3	$239K	Sell	23,930 -204	-0.8%	-$2.04K	0.03%	177
2021 Q2	$342K	Buy	24,134 +3,853	+19%	+$54.6K	0.05%	166
2021 Q1	$333K	Buy	+20,281	New	+$333K	0.05%	138